期刊文献+

抗T细胞受体αβ单克隆抗体促进异基因小鼠皮肤移植耐受及其机制的研究 被引量:6

Study on the improved effect of anti-TCR α β monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms
原文传递
导出
摘要 目的 探讨静脉注射异基因脾细胞 (SC)和抗T细胞受体 (TCR)αβ单克隆抗体加腹腔注射环磷酰胺 (CP)诱导的成年小鼠异基因皮肤移植耐受及其形成的机制。方法 对C5 7BL/ 6 (H 2 b,B6 )小鼠经尾静脉注射BALB/c小鼠 (H 2 d)脾细胞 ,2d后腹腔注射CP ,之后第 2、4天分别经尾静脉注射抗小鼠 TCRαβ的单克隆抗体 ,然后进行皮肤移植。分组 :(1)未处理B6小鼠 ,皮肤供者为BALB/c小鼠 ;(2 )未处理B6小鼠 ,皮肤供者为KM小鼠 ;(3)SC +CP +抗TCRαβ单抗处理的B6小鼠 ,皮肤供者为BALB/c小鼠 ;(4)SC +CP +抗TCRαβ单抗处理的B6小鼠 ,皮肤供者为KM小鼠。每组各 5只B6小鼠通过嵌合体检查、过继转移实验及外源白细胞介素 2 (IL 2 )对耐受小鼠供体特异性混合淋巴细胞反应 (MLR)的影响 ,探讨耐受形成的机制。采用成组t检验进行统计学分析。结果 BALB/c小鼠的皮肤移植物在耐受B6小鼠中存活 6 6 3d ,与各对照组比较 ,差异有显著意义 (P <0 0 0 1) ,流式细胞分析仪分析结果表明 ,耐受小鼠胸腺和脾脏内均形成了微量混合嵌合体 ,耐受诱导后第 15天、35天和第70天胸腺内供体来源细胞嵌合水平依次为 2 6 7% ,1 6 1% ,0 47% ,脾脏中依次为 7 6 6 % ,5 99% ,3 87% ;体、内外细胞转移实验均未显示耐受小鼠脾细胞中存在抑制细? Objective To study skin allograft tolerance induced by intravenous injection of allogeneic spleen cells and intraperitoneal injection of cyclophosphamide (CP), followed by anti TCR monoclonal antibody injections in adult recipient mice and its mechanisms. Methods Injecting the spleen cells of BALB/c mice (H 2 d) were injected to C57BL/6 mice (H 2 b, B6) via the tail vein. Two days later an intraperioneal injection of cyclophosphamide was given to the B6 mice, and followed by anti TCRαβ monoclonal antibody injection via the tail vein, after which skin of BALB/c mice were grafted to the tolerance induced B6 mice. The control groups were: (1) normal B6 mice grafted with BABL/c skin; (2) normal B6 mice grafted with KM skin; (3) B6 mice treated with SC+CP+anti TCR α β monoclonal antibody administration and grafted with BALB/c skin allograft; (4) B6 mice treated as group 3, and grafted with KM skin instead of BALB/c skin. Detection of chimerism, adoptive transfer assay and the effect of exogenous IL 2 on MLR were performed to explore tolerance mechenisms. Group data in each experiment were compared with Group′s t test. Results The survival of BALB/c skin allograft in recipient B6 mice was 66.3 days, P <0.001 compared with the other three groups. The results of FACS analysis showed that a mixed microchimerism was developed in the thymus and spleen of tolerant mice. The percentage of cells of BALB/c origin in the thymus on day 15, 35, and 70 after induction of tolerance was 2.67%, 1.61%, and 0.47%, and in the spleen is 7.66%, 5.99%, and 3.87%, respectively. No suppressive activity in the spleen cells of tolerant mice was observed by in vivo and in vitro cell transfer experiments. MLR of spleen cells in the tolerant B6 mice to spleen cells of BALB/c origin was specifically suppressed, which was 4 725±406 cpm by 3?H TdR incorporation. However, the specific inhibition of MLR of tolerant B6 mice could be partially reversed ( P <0 01), the 3?H TdR incorporation reached 18 175±3 642 cpm by adding exogenous IL 2. Conclusion Chimerism and clonal anergy are the main mechanisms of the tolerance.
出处 《中华医学杂志》 CAS CSCD 北大核心 2001年第10期593-596,共4页 National Medical Journal of China
基金 国家自然科学基金重点资助项目 ( 39830340 )
关键词 同种异基因移植 免疫耐受 嵌合体 抗T细胞受体 β单克隆抗体 皮肤移植 Allogeneic transplantation Immune tolerance Chimerism
  • 相关文献

参考文献3

共引文献3

同被引文献23

  • 1白爱林,谢蜀生,龙振洲.成年小鼠皮肤移植耐受诱导的实验研究[J].中国免疫学杂志,1994,10(5):274-277. 被引量:15
  • 2Hermans IF,Daish A,Moroni-Rawson P,et al.Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge[J].Cancer Immunol Immunother,1997,44(6):341-347.
  • 3Roelen DL,Schuurhuis DH,van den Boogaardt DE,et al.Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells[J].Transplantation,2003,76(11):1 608-1 615.
  • 4Steinbrink K,Graulich E,Kubsch S,et al.CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity[J].Blood,2002,99(7):2 468-2 476.
  • 5Wekerle T, Kurtz J, Ito H, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment [ J ]. Nat Med,2000, 6:464-469.
  • 6Koyama I, Kawai T, Andrews D, et al. Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates [ J ]. Transplantation, 2004, 77 : 460 -462.
  • 7Crowe JE, Sannella EC, Pfeiffer S, et al. CD154 regulates primate humoral immunity to influenza[ J ]. Am J Transplant, 2003,3:680 - 688.
  • 8Siemionow M, Ozer K, Lzycki D, et al. A new method of bone marrow transplantation leads to extention of skin allograft survival[J]. Transplant Proc, 2005, 37:2309 -2314.
  • 9Nomoto K, Kong YY, Omoto K, et al. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-αβ monoclonal antibody, low dose irradiation, and donor bone marrow transfusion [ J ]. Transplantation, 1995, 59:395 - 401.
  • 10Siemionow MZ, Izycki DM, Zielinski M, et al. Donor-specific tolerance in fully major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol[ J ]. Transplantation,2003, 76 : 1662 - 1668.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部